Comment on: Conversion of sleeve gastrectomy to Roux-en-Y laparoscopic gastric bypass: a comprehensive 14-year follow-up study on efficacy and outcomes.

Surg Obes Relat Dis

ELSAN, Clinique Saint Michel, Centre Chirurgical de l'Obésité, Toulon, France; Endocrine, Metabolic and Bariatric Unit, General Surgery Department, Hospital Vall d'Hebron, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soard.2024.10.006DOI Listing

Publication Analysis

Top Keywords

comment conversion
4
conversion sleeve
4
sleeve gastrectomy
4
gastrectomy roux-en-y
4
roux-en-y laparoscopic
4
laparoscopic gastric
4
gastric bypass
4
bypass comprehensive
4
comprehensive 14-year
4
14-year follow-up
4

Similar Publications

Introduction: Resection of primary tumor and liver metastases is the gold standard for colorectal cancer with liver-only metastases (CRLM). Although treatment options have expanded to enable conversion of unresectable to resectable CRLM, about 40% of patients will have definitively unresectable disease. Major advances in surgical techniques, immunosuppressive protocols and patient selection criteria for liver transplantation have resulted in improved outcomes.

View Article and Find Full Text PDF

Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions.

World J Gastrointest Oncol

October 2024

Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

Recently, we read the article "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature" published in the . The prognosis of advanced hepatocellular carcinoma (HCC) is poor, and multidisciplinary comprehensive treatment is currently the main research direction. This case report demonstrated the efficacy of the combination therapy of transcatheter arterial chemoembolization, hepatic arterial infusion chemotherapy, epclusa, lenvatinib and sintilimab for a patient with advanced HCC, and the report can serve as a reference for clinical practice.

View Article and Find Full Text PDF

In this editorial, I comment on three articles published in the recent issue of the . Hepatocellular carcinoma (HCC) is an important public health concern, and there are three articles on the theme of HCC in this issue. I focus on the articles by Mu , Chu , and Ma for this editorial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!